Clinical Trials Directory

Trials / Completed

CompletedNCT06165042

Silver Diamine Fluoride in Molar-Incisor Hypomineralisation

Evaluation of Silver Diamine Fluoride Application in Molar-Incisor Hypomineralisation-Affected Molars

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Marmara University · Academic / Other
Sex
All
Age
8 Years – 13 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to assess the efficacy of silver diamine fluoride application in molars affected by molar-incisor hypomineralization. Additionally, the study aims to evaluate the effectiveness of the combined application of silver diamine fluoride, commonly used for dentin hypersensitivity, with a glass hybrid restorative system. The goal is to mitigate sensitivity and improve chewing functions in teeth affected by molar-incisor hypomineralization.

Detailed description

In a research study focusing on 120 children aged 8-13 with molar incisor hypomineralization (MIH), a comprehensive examination of 240 teeth will be conducted. Study will employ selective caries removal to eliminate decay and subsequently apply restorations. The two intervention groups are delineated as follows: Group 1: Glass hybrid restorative system (Equia Forte, GC Europe, Leuven, Belgium) Group 2 : Restoration involving fluoride varnish (SDI Riva Star) + glass hybrid restorative system (Equia Forte, GC Europe, Leuven, Belgium)

Conditions

Interventions

TypeNameDescription
OTHERglass hybrid restorative systemIn the teeth where the indication is identified, selective caries removal will be performed to eliminate the decayed tooth tissue. Subsequently, for each patient in the study apply glass hybrid restorative system (Equia Forte, GC Europe, Leuven, Belgium)
OTHERFluoride varnish + Glass hybrid restorative systemIn the teeth where the indication is identified, selective caries removal will be performed to eliminate the decayed tooth tissue. Subsequently, for each patient in the study apply Fluoride varnish (SDI Riva Star)+ Glass hybrid restorative (Equia Forte, GC Europe, Leuven, Belgium)

Timeline

Start date
2024-04-01
Primary completion
2024-12-26
Completion
2025-01-30
First posted
2023-12-11
Last updated
2026-04-06

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06165042. Inclusion in this directory is not an endorsement.